文献速递心脑血管急症

双侧与单侧胸廓内动脉移植的随机试验

Randomized Trial of Bilateral versus Single Internal-Thoracic-Artery Grafts.
PubMed 文献 · N Engl J Med · 2016-11-14
一句话结论在计划行冠状动脉旁路移植术的患者中,双侧与单侧胸廓内动脉移植5年随访的全因死亡和心血管事件无显著差异,但双侧移植的胸骨伤口并发症更多。

该研究在7个国家28个心脏外科中心随机分配3102例计划行冠状动脉旁路移植术的患者,1554例接受单侧胸廓内动脉移植(单侧移植组),1548例接受双侧胸廓内动脉移植(双侧移植组)。5年随访时,双侧移植组死亡率为8.7%,单侧移植组为8.4%(HR 1.04;95%CI 0.81-1.32;P=0.77);复合终点(全因死亡、心肌梗死或卒中)发生率分别为12.2%和12.7%(HR 0.96;95%CI 0.79-1.17;P=0.69)。双侧移植组胸骨伤口并发症发生率为3.5%,单侧移植组为1.9%(P=0.005);胸骨重建率分别为1.9%和0.6%(P=0.002)。结论认为5年随访时两组死亡率和心血管事件率无显著差异,双侧移植胸骨伤口并发症更多,10年随访正在进行中。

要点

  • 在计划行冠状动脉旁路移植术的患者中,双侧移植组5年死亡率为8.7%,单侧移植组为8.4%(HR 1.04;95%CI 0.81-1.32;P=0.77),无显著差异。
  • 双侧移植组5年复合终点(全因死亡、心肌梗死或卒中)发生率为12.2%,单侧移植组为12.7%(HR 0.96;95%CI 0.79-1.17;P=0.69),无显著差异。
  • 双侧移植组胸骨伤口并发症发生率为3.5%,单侧移植组为1.9%(P=0.005)。
  • 双侧移植组胸骨重建率为1.9%,单侧移植组为0.6%(P=0.002)。
  • 10年随访仍在进行中。

适用人群与场景

  • 计划行冠状动脉旁路移植术的患者,来自7个国家28个心脏外科中心。

研究设计与关键结果

  • 研究类型为随机对照试验,共纳入3102例患者,其中单侧移植组1554例,双侧移植组1548例。
  • 5年随访时,双侧移植组死亡率为8.7%,单侧移植组为8.4%(HR 1.04;95%CI 0.81-1.32;P=0.77)。
  • 5年随访时,双侧移植组复合终点(全因死亡、心肌梗死或卒中)发生率为12.2%,单侧移植组为12.7%(HR 0.96;95%CI 0.79-1.17;P=0.69)。
  • 双侧移植组胸骨伤口并发症发生率为3.5%,单侧移植组为1.9%(P=0.005)。
  • 双侧移植组胸骨重建率为1.9%,单侧移植组为0.6%(P=0.002)。

证据类型、等级与局限

  • 证据类型为随机对照试验(RCT),由英国心脏基金会等资助,ART试验注册号ISRCTN46552265。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 在计划行冠状动脉旁路移植术的患者中,选择双侧胸廓内动脉移植时需权衡5年随访时胸骨伤口并发症(3.5% vs 1.9%)和胸骨重建(1.9% vs 0.6%)风险高于单侧移植,而死亡率和心血管事件率无显著差异。
  • 原文未据此给出推荐。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: The use of bilateral internal thoracic (mammary) arteries for coronary-artery bypass grafting (CABG) may improve long-term outcomes as compared with the use of a single internal-thoracic-artery plus vein grafts.

METHODS: We randomly assigned patients scheduled for CABG to undergo single or bilateral internal-thoracic-artery grafting in 28 cardiac surgical centers in seven countries. The primary outcome was death from any cause at 10 years. The composite of death from any cause, myocardial infarction, or stroke was a secondary outcome. Interim analyses were prespecified at 5 years of follow-up.

RESULTS: A total of 3102 patients were enrolled; 1554 were randomly assigned to undergo single internal-thoracic-artery grafting (the single-graft group) and 1548 to undergo bilateral internal-thoracic-artery grafting (the bilateral-graft group). At 5 years of follow-up, the rate of death was 8.7% in the bilateral-graft group and 8.4% in the single-graft group (hazard ratio, 1.04; 95% confidence interval [CI], 0.81 to 1.32; P=0.77), and the rate of the composite of death from any cause, myocardial infarction, or stroke was 12.2% and 12.7%, respectively (hazard ratio, 0.96; 95% CI, 0.79 to 1.17; P=0.69). The rate of sternal wound complication was 3.5% in the bilateral-graft group versus 1.9% in the single-graft group (P=0.005), and the rate of sternal reconstruction was 1.9% versus 0.6% (P=0.002).

CONCLUSIONS: Among patients undergoing CABG, there was no significant difference between those receiving single internal-thoracic-artery grafts and those receiving bilateral internal-thoracic-artery grafts with regard to mortality or the rates of cardiovascular events at 5 years of follow-up. There were more sternal wound complications with bilateral internal-thoracic-artery grafting than with single internal-thoracic-artery grafting. Ten-year follow-up is ongoing. (Funded by the British Heart Foundation and others; ART Current Controlled Trials number, ISRCTN46552265 .).

来源:N Engl J Med,查看原文。版权归原作者所有。

参考来源

  1. Taggart DP, Altman DG, Gray AM, et al. Randomized Trial of Bilateral versus Single Internal-Thoracic-Artery Grafts. N Engl J Med. 2016. PMID: 27959712. doi:10.1056/NEJMoa1610021

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。